Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC
Clinical trial NCT06752382 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06752382
- Sponsor
- Zhejiang Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2027-12-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.